{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:34:20Z","timestamp":1759581260680},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1038\/sj.bmt.1702451","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:42:19Z","timestamp":1031154139000},"page":"17-22","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients"],"prefix":"10.1038","volume":"26","author":[{"given":"A","family":"Schattenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Preijers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"van der Maazen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,7,7]]},"reference":[{"key":"BF1702451_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/sj.bmt.1700710","volume":"19","author":"HM Lazarus","year":"1997","unstructured":"Lazarus HM, Vogelsang GB, Rowe JM . Prevention and treatment of acute-graft-versus host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG) Bone Marrow Transplant 1997 19: 577\u2013600","journal-title":"Bone Marrow Transplant"},{"key":"BF1702451_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2141.1987.tb06160.x","volume":"67","author":"RP Gale","year":"1987","unstructured":"Gale RP, Bortin MM, Van Bekkum DW et al. Risk factors for acute graft-versus-host disease Br J Haematol 1987 67: 397\u2013406","journal-title":"Br J Haematol"},{"key":"BF1702451_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(87)90763-X","volume":"2","author":"D Maraninchi","year":"1987","unstructured":"Maraninchi D, Blaise D, Rio B et al. Impact of T cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias Lancet 1987 2: 175\u2013178","journal-title":"Lancet"},{"key":"BF1702451_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.7326\/0003-4819-108-6-806","volume":"108","author":"JM Goldman","year":"1988","unstructured":"Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myeloid leukemia in chronic phase: increased rate of relapse associated with T cell depletion Ann Intern Med 1988 108: 806\u2013814","journal-title":"Ann Intern Med"},{"key":"BF1702451_CR5","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","volume":"78","author":"AM Marmont","year":"1991","unstructured":"Marmont AM, Horowitz MM, Gale RP et al. T cell depletion of HLA-identical transplants in leukemia Blood 1991 78: 2120\u20132130","journal-title":"Blood"},{"key":"BF1702451_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/10428199209058645","volume":"7","author":"P Muus","year":"1992","unstructured":"Muus P, DeWitte T, Schattenberg A et al. Intensification of the conditioning regimen for allogeneic bone marrow transplantation in recipients of T cell-depleted grafts by the addition of anthracyclines Leuk Lymphoma 1992 7: 11\u201314","journal-title":"Leuk Lymphoma"},{"key":"BF1702451_CR7","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M et al. Engraftment of hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531\u20134536","journal-title":"Blood"},{"key":"BF1702451_CR8","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Keating M, K\u00f6rbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J CIin Oncol 1998 16: 2817\u20132824","journal-title":"J CIin Oncol"},{"key":"BF1702451_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.bmt.1700824","volume":"19","author":"A Schattenberg","year":"1997","unstructured":"Schattenberg A, Preijers F, Mensink E et al. Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia-chromosome positive CML in first chronic phase Bone Marrow Transplant 1997 19: 1205\u20131212","journal-title":"Bone Marrow Transplant"},{"key":"BF1702451_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1046\/j.1365-2141.1997.d01-3499.x","volume":"98","author":"N Schaap","year":"1997","unstructured":"Schaap N, Schattenberg A, B\u00e4r B et al. Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen Br J Haematol 1997 98: 750\u2013759","journal-title":"Br J Haematol"},{"key":"BF1702451_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. CIinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295\u2013304","journal-title":"Transplantation"},{"key":"BF1702451_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man Am J Med 1980 69: 204\u2013217","journal-title":"Am J Med"},{"key":"BF1702451_CR13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"H-J Kolb","year":"1995","unstructured":"Kolb H-J, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041\u20132050","journal-title":"Blood"},{"key":"BF1702451_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1993.03510010063030","volume":"270","author":"O Ringd\u00e9n","year":"1993","unstructured":"Ringd\u00e9n O, Horowitz MM, Gale RP et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults JAMA 1993 270: 57\u201360","journal-title":"JAMA"},{"key":"BF1702451_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1200\/JCO.1992.10.7.1191","volume":"10","author":"RJ Soiffer","year":"1992","unstructured":"Soiffer RJ, Murray C, Mauch P et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow J CIin Oncol 1992 10: 1191\u20131200","journal-title":"J CIin Oncol"},{"key":"BF1702451_CR16","first-page":"1","volume":"17","author":"F Frassoni","year":"1996","unstructured":"Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time \u2013 a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT) Bone Marrow Transplant 1996 17: 1\u201318","journal-title":"Bone Marrow Transplant"},{"key":"BF1702451_CR17","first-page":"993","volume":"17","author":"S Keating","year":"1996","unstructured":"Keating S, Suciu S, DeWitte T et al. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell\u2019 Adulto (GIMEMA) leukemia cooperative groups Bone Marrow Transplant 1996 17: 993\u20131001","journal-title":"Bone Marrow Transplant"},{"key":"BF1702451_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM198903303201303","volume":"320","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Storb R, Buckner DC et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms New Engl J Med 1989 320: 828\u2013834","journal-title":"New Engl J Med"},{"key":"BF1702451_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2141.1995.tb08356.x","volume":"89","author":"E Naparstek","year":"1995","unstructured":"Naparstek E, Or R, Nagler A et al. T cell-depleted allogeneic bone marrow transplantation for acute leukemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse Br J Haematol 1995 89: 506\u2013515","journal-title":"Br J Haematol"},{"key":"BF1702451_CR20","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756\u2013763","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702451","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:35:28Z","timestamp":1648071328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["BF1702451"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702451","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,1]]},"assertion":[{"value":"4 January 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}